Avedro, Inc. Announces Preparation for Anticipated Hyperopic Lasik Xtra® U.S. Clinical Trial
3/13/2013 9:18:12 AM
More...
|
Avedro, Inc. Announces Preparation for Anticipated Hyperopic Lasik Xtra® U.S. Clinical Trial
3/13/2013 9:05:36 AM
More...
|
Avedro, Inc. Raises $43 Million in Pursuit of FDA Approval for Lasik Device
3/5/2013 7:33:04 AM
More...
|
Avedro, Inc. Release: Keraflex® Keratoconus Treatment Study Begins in U.S.
10/12/2012 9:55:44 AM
More...
|
Avedro, Inc. Announces CE Mark for its Newest Riboflavin Formulations
6/12/2012 8:05:20 AM
More...
|
Avedro, Inc. to Present Seven Scientific Research Posters at Leading Ophthalmic Meeting
5/2/2012 10:06:36 AM
More...
|
ACOS and Avedro, Inc. Announce Initiation of a Phase 3 Study on Accelerated Corneal Cross-Linking
4/3/2012 10:35:05 AM
More...
|
Avedro, Inc. Announces FDA Submission for Corneal Cross-linking
3/9/2012 6:44:40 AM
More...
|
Avedro, Inc. Announces FDA Submission for Corneal Cross-linking
3/8/2012 10:40:29 AM
More...
|
Avedro, Inc. Options Rights to Intellectual Property
2/29/2012 7:22:03 AM
More...
|
|